Autoimmune Diseases Curation Project

Evergreen

Autoimmune Diseases Curation Project

Overview

Comprehensive curation of autoimmune diseases for the dismech knowledge base, covering diverse autoimmune mechanisms including organ-specific, systemic, and autoinflammatory conditions.

This is an evergreen project: beyond the initial diseases, "Other" expansion categories capture related conditions that share autoimmune mechanisms and can be unfolded as curation continues.

Existing Autoimmune Diseases in KB (14)

These are already in the knowledge base and may benefit from enhancement:

Disease File Status
Hashimoto's Thyroiditis Hashimotos_Thyroiditis.yaml ✓ Curated
Graves' Disease Graves_Disease.yaml ✅ Enhanced (81.9%)
Celiac Disease Celiac_Disease.yaml ✓ Curated
Multiple Sclerosis Multiple_Sclerosis.yaml ✅ Enhanced (92.0%)
Rheumatoid Arthritis Rheumatoid_Arthritis.yaml ✅ Enhanced (87.6%)
Systemic Lupus Erythematosus Systemic_Lupus_Erythematosus.yaml ✅ Enhanced (79.4%)
Type 1 Diabetes Type_I_Diabetes.yaml ✅ Enhanced (60.2%)
Psoriasis Psoriasis.yaml ✓ Curated
Ulcerative Colitis Ulcerative_Colitis.yaml ✓ Curated
Crohn's Disease Crohn_Disease.yaml ✅ Enhanced (76.2%)
Vitiligo Vitiligo.yaml ✅ Enhanced (86.7%)
Addison's Disease Addisons_Disease.yaml ✅ Enhanced (77.7%)
Antiphospholipid Syndrome Antiphospholipid_Syndrome.yaml Needs review (89.8%)
Stiff Person Syndrome Stiff_Person_Syndrome.yaml ✅ Complete (100%)

New Autoimmune Diseases to Curate (20)

Systemic Autoimmune Diseases

Disease File Status Evidence Items
Sjögren's Syndrome Sjogrens_Syndrome.yaml ✅ Complete 9
Scleroderma (Systemic Sclerosis) Systemic_Sclerosis.yaml ✅ Complete 6
Mixed Connective Tissue Disease Mixed_Connective_Tissue_Disease.yaml ✅ Complete 9
Dermatomyositis Dermatomyositis.yaml ✅ Complete 12
Polymyositis Polymyositis.yaml ✅ Complete 11
Other systemic autoimmune [ ] e.g. adult Still disease, relapsing polychondritis

Neurological Autoimmune Diseases

Disease File Status Evidence Items
Myasthenia Gravis Myasthenia_Gravis.yaml ✅ Complete 9
Guillain-Barré Syndrome Guillain_Barre_Syndrome.yaml ✅ Complete 7
CIDP Chronic_Inflammatory_Demyelinating_Polyneuropathy.yaml ✅ Complete 6
Other neurological autoimmune [ ] e.g. autoimmune encephalitis, neuromyelitis optica, ADEM

Musculoskeletal Autoimmune Diseases

Disease File Status Evidence Items
Ankylosing Spondylitis Ankylosing_Spondylitis.yaml ✅ Complete 9
Other spondyloarthropathies [ ] e.g. psoriatic arthritis, reactive arthritis, enteropathic arthritis

Hepatobiliary Autoimmune Diseases

Disease File Status Evidence Items
Primary Biliary Cholangitis Primary_Biliary_Cholangitis.yaml ✅ Complete 9
Autoimmune Hepatitis Autoimmune_Hepatitis.yaml ✅ Complete 6
Primary Sclerosing Cholangitis Primary_Sclerosing_Cholangitis.yaml ✅ Complete 7
Other hepatobiliary autoimmune [ ] e.g. IgG4-related cholangitis, overlap syndromes

Vasculitis

Disease File Status Evidence Items
Giant Cell Arteritis Giant_Cell_Arteritis.yaml ✅ Complete 9
Granulomatosis with Polyangiitis Granulomatosis_with_Polyangiitis.yaml ✅ Complete 10
Behçet's Disease Behcets_Disease.yaml ✅ Complete 6
Other large vessel vasculitis [ ] e.g. Takayasu arteritis
Other small vessel vasculitis [ ] e.g. microscopic polyangiitis, eosinophilic GPA, anti-GBM disease

Dermatological Autoimmune Diseases

Disease File Status Evidence Items
Pemphigus Vulgaris Pemphigus_Vulgaris.yaml ✅ Complete 7
Alopecia Areata Alopecia_Areata.yaml ✅ Complete 10
Other bullous autoimmune [ ] e.g. bullous pemphigoid, dermatitis herpetiformis, epidermolysis bullosa acquisita

Hematological Autoimmune Diseases

Disease File Status Evidence Items
Autoimmune Hemolytic Anemia Autoimmune_Hemolytic_Anemia.yaml ✅ Complete 7
Immune Thrombocytopenia (ITP) Immune_Thrombocytopenia.yaml ✅ Complete 7
Other hematological autoimmune [ ] e.g. autoimmune neutropenia, Evans syndrome, TTP

Renal Autoimmune Diseases

Disease File Status Evidence Items
IgA Nephropathy IgA_Nephropathy.yaml ✅ Complete 7
Other renal autoimmune [ ] e.g. membranous nephropathy, lupus nephritis, anti-GBM nephritis

Progress

Key Autoimmune Mechanisms to Cover

  1. Antibody-mediated - autoantibodies targeting self-antigens (e.g., anti-AChR in MG, anti-dsDNA in SLE)
  2. T cell-mediated - autoreactive T cells attacking tissues (e.g., MS, T1D)
  3. Immune complex deposition - circulating immune complexes causing tissue damage
  4. Complement activation - complement-mediated tissue destruction
  5. Cytokine dysregulation - aberrant inflammatory cytokine production
  6. Molecular mimicry - cross-reactivity between pathogen and self-antigens
  7. Epitope spreading - expansion of autoimmune response to additional self-antigens

Common Autoantibodies to Document


STATUS

New Diseases (20/20 Complete)

Existing Diseases Needing Enhancement (9/10)

Expansion Categories

NOTES

2025-12-18 (Session 3)

Enhanced 5 existing autoimmune disease files: - Graves' Disease: 77.7% -> 81.9% - Added evidence for CTLA4 (PMID:10404810) - Added evidence for PTPN22 (PMID:33103521) - Added evidence for CD40 (PMID:12593727) - Added evidence for TSHR (PMID:27231040) - Systemic Lupus Erythematosus: 77.6% -> 79.4% - Added evidence for Anifrolumab (PMID:28130918) - Added evidence for Belimumab (PMID:22127708) - Vitiligo: 80.0% -> 86.7% - Added evidence for IFIH1 (PMID:22561518) - Added evidence for BACH2 (PMID:22561518) - Added evidence for IRF4 (PMID:27723757) - Added evidence for FOXP3 (PMID:33181260) - Rheumatoid Arthritis: 83.0% -> 87.6% - Added evidence for JAK/STAT Signaling (PMID:35367240) - Added evidence for PADI4 (PMID:17893996) - Multiple Sclerosis: 86.6% -> 92.0% - Added evidence for IL7R (PMID:17660530) - Added evidence for IL2RA (PMID:17660530)

All additions passed validation (schema, term, and reference checks).

2025-12-18 (Session 2)

Enhanced 3 existing autoimmune disease files: - Type 1 Diabetes: 53.7% -> 60.2% (66.4% weighted) - Added evidence for interferon-driven beta cell response (PMID:38409439) - Added evidence for HLA-DQ2 (PMID:22184118) - Added evidence for PTPN22 (PMID:15734872) - Added evidence for IL2RA (PMID:22461703) - Added evidence for CTLA4 (PMID:9353155) - Added evidence for Teplizumab (PMID:36877454) - Added evidence for CGM (PMID:34872983) - Addison's Disease: 73.4% -> 77.7% (81.5% weighted) - Added evidence for CYP21A2 autoantigen (PMID:34665570) - Added evidence for HLA-DR3-DQ2/DR4-DQ8 (PMID:12392510) - Added evidence for CTLA4 (PMID:26204230) - Added evidence for PTPN22 (PMID:18301444) - Crohn's Disease: 75.2% -> 76.2% (79.8% weighted) - Added evidence for autophagy/Paneth cell dysfunction (PMID:18849966)

All additions passed validation (schema, term, and reference checks).

2025-12-18 (Session 1)